Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heng Cui

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Molecular Cancer Therapeutics|July 5, 2021
Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter StudyHong Zheng, Yunong Gao, Hongyan Guo, et al.
Cancer Research|August 15, 2022
Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian CancerYicheng Wang, Haoling Xie, Xiaohong Chang, et al.
JAMA Oncology|July 13, 2023
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical TrialNing Li, Jianqing Zhu, Rutie Yin, et al.
Eclinicalmedicine|May 15, 2024
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trialXiaohua Wu, Jianqing Zhu, Rutie Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2022
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III TrialNing Li, Youzhong Zhang, Jing Wang, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Molecular Cancer Therapeutics|July 5, 2021
Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter StudyHong Zheng, Yunong Gao, Hongyan Guo, et al.
Cancer Research|August 15, 2022
Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous Ovarian CancerYicheng Wang, Haoling Xie, Xiaohong Chang, et al.
JAMA Oncology|July 13, 2023
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Phase 3 Randomized Clinical TrialNing Li, Jianqing Zhu, Rutie Yin, et al.
Eclinicalmedicine|May 15, 2024
Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trialXiaohua Wu, Jianqing Zhu, Rutie Yin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2022
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III TrialNing Li, Youzhong Zhang, Jing Wang, et al.
Pageof 13